Lack of a Significant Drug Interaction between Raltegravir and Tenofovir

Raltegravir is a novel human immunodeficiency virus type 1 (HIV-1) integrase inhibitor with potent in vitro activity (95% inhibitory concentration of 31 nM in 50% human serum). This article reports the results of an open-label, sequential, three-period study of healthy subjects. Period 1 involved ra...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Wenning, Larissa A., Friedman, Evan J., Kost, James T., Breidinger, Sheila A., Stek, Jon E., Lasseter, Kenneth C., Gottesdiener, Keith M., Chen, Joshua, Teppler, Hedy, Wagner, John A., Stone, Julie A., Iwamoto, Marian
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: American Society for Microbiology (ASM) 2008
Pynciau:
Antiviral Agents
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2533504/
https://ncbi.nlm.nih.gov/pubmed/18625763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00005-08
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg